Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsRogier A. Oldenburg, P. Andrew Futreal|Nature Genetics|2002Cited by 1.1k
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT StudyElizabeth Bancroft, Apollonia T. Helderman-van den Enden, Elizabeth Page et al.|European Urology|2014Cited by 250
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation CarriersElizabeth Page, Manuel R. Teixeira, Natalie Taylor et al.|European Urology|2019Cited by 239